Solid Biosciences Inc. SEC filings SLDB
Solid Biosciences Inc. has 737 filings in SEC EDGAR's recent list, going back to Aug 4, 2017. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Other events
|
Aug 6, 2026 | Aug 6, 2026 |
| 424B5 | Prospectus supplement | Aug 6, 2026 | — |
| S-3ASR | Automatic shelf registration | Aug 6, 2026 | — |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2026 | Jun 10, 2026 |
| 424B7 | Filing | Jun 5, 2026 | — |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| ARS | Annual report to shareholders | Apr 23, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 23, 2026 | — |
| DEF 14A | Proxy statement | Apr 23, 2026 | Jun 10, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 10, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 10, 2026 | Apr 10, 2026 |
| EFFECT | Filing | Mar 31, 2026 | — |
| EFFECT | Filing | Mar 31, 2026 | — |
| CORRESP | Letter to the SEC | Mar 27, 2026 | — |
| CORRESP | Letter to the SEC | Mar 27, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 24, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 24, 2026 | — |
| S-3 | Shelf registration | Mar 19, 2026 | — |
| S-3 | Shelf registration | Mar 19, 2026 | — |
| S-8 | Employee stock plan registration | Mar 19, 2026 | — |
| 10-K | Annual report | Mar 19, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 12, 2026 | Mar 11, 2026 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Other events
|
Mar 6, 2026 | Mar 6, 2026 |
| 10-Q | Quarterly report | Nov 3, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Nov 3, 2025 | Nov 3, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 13, 2025 | Jun 12, 2025 |
| S-8 | Employee stock plan registration | Jun 13, 2025 | — |
| EFFECT | Filing | May 27, 2025 | — |
| CORRESP | Letter to the SEC | May 22, 2025 | — |
| UPLOAD | Letter from the SEC | May 21, 2025 | — |
| 8-K |
Current report
Other events
|
May 15, 2025 | May 15, 2025 |
| 424B5 | Prospectus supplement | May 15, 2025 | — |
| S-3 | Shelf registration | May 15, 2025 | — |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 12, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 11, 2025 | Jun 12, 2025 |
| EFFECT | Filing | Mar 14, 2025 | — |
| EFFECT | Filing | Mar 14, 2025 | — |
| CORRESP | Letter to the SEC | Mar 12, 2025 | — |
| CORRESP | Letter to the SEC | Mar 12, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 11, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 11, 2025 | — |
| S-3 | Shelf registration | Mar 6, 2025 | — |
| S-3 | Shelf registration | Mar 6, 2025 | — |
| S-8 | Employee stock plan registration | Mar 6, 2025 | — |
| 10-K | Annual report | Mar 6, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 18, 2025 | Feb 18, 2025 |
| 424B5 | Prospectus supplement | Feb 18, 2025 | — |
| FWP | Free writing prospectus | Feb 18, 2025 | — |
| 8-K |
Current report
Other events
|
Feb 18, 2025 | Feb 18, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 18, 2025 | Feb 18, 2025 |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 11, 2024 | Jun 7, 2024 |
| S-8 | Employee stock plan registration | Jun 11, 2024 | — |
| EFFECT | Filing | May 17, 2024 | — |
| CORRESP | Letter to the SEC | May 15, 2024 | — |
| S-3/A | Filing | May 15, 2024 | — |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 11, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 12, 2024 | Jun 11, 2024 |
| UPLOAD | Letter from the SEC | Mar 18, 2024 | — |
| S-3 | Shelf registration | Mar 13, 2024 | — |
| S-8 | Employee stock plan registration | Mar 13, 2024 | — |
| 10-K | Annual report | Mar 13, 2024 | Dec 31, 2023 |
| EFFECT | Filing | Feb 8, 2024 | — |
| CORRESP | Letter to the SEC | Feb 6, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 5, 2024 | — |
| S-3 | Shelf registration | Jan 30, 2024 | — |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure, Other events
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 15, 2023 | Nov 14, 2023 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 9, 2023 | Jun 6, 2023 |
| S-8 | Employee stock plan registration | Jun 6, 2023 | — |
| 8-K |
Current report
Officer or director change
|
May 22, 2023 | May 22, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| ARS | Annual report to shareholders | Apr 27, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 27, 2023 | — |
| DEF 14A | Proxy statement | Apr 27, 2023 | Jun 6, 2023 |
| 424B5 | Prospectus supplement | Mar 23, 2023 | — |
| S-8 | Employee stock plan registration | Mar 23, 2023 | — |
| 10-K | Annual report | Mar 23, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 20, 2023 | Mar 19, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 13, 2023 |
| EFFECT | Filing | Feb 6, 2023 | — |
| CORRESP | Letter to the SEC | Feb 2, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 1, 2023 | — |
| S-3 | Shelf registration | Jan 26, 2023 | — |
| S-8 | Employee stock plan registration | Jan 9, 2023 | — |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure, Other events
|
Jan 9, 2023 | Jan 6, 2023 |
| D | Filing | Dec 9, 2022 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Exit or restructuring costs, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Dec 5, 2022 | Nov 30, 2022 |
| S-8 | Employee stock plan registration | Dec 2, 2022 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Dec 1, 2022 | Dec 1, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| DEFM14A | Filing | Nov 7, 2022 | — |
| PREM14A | Filing | Oct 28, 2022 | Oct 28, 2022 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Oct 27, 2022 | Oct 27, 2022 |
| DEFA14A | Additional proxy material | Sep 30, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 30, 2022 | Sep 30, 2022 |
| DEFA14A | Additional proxy material | Sep 30, 2022 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure, Other events
|
Sep 30, 2022 | Sep 29, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2022 | Jun 7, 2022 |
| 8-K |
Current report
Listing notice
|
Jun 6, 2022 | May 31, 2022 |
| S-8 | Employee stock plan registration | Jun 1, 2022 | — |
| DEFA14A | Additional proxy material | Apr 28, 2022 | — |
| DEF 14A | Proxy statement | Apr 28, 2022 | Jun 7, 2022 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Apr 27, 2022 | Apr 22, 2022 |
| 10-Q | Quarterly report | Apr 27, 2022 | Mar 31, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2022 | Jun 7, 2022 |
| 8-K | Current report | Apr 4, 2022 | Mar 30, 2022 |
| 10-K | Annual report | Mar 14, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 10, 2022 | Jan 10, 2022 |
| 10-Q | Quarterly report | Nov 3, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Other events
|
Sep 29, 2021 | Sep 29, 2021 |
| 8-K/A |
Amended current report
Other events
|
Sep 27, 2021 | Sep 23, 2021 |
| 8-K |
Current report
Other events
|
Sep 23, 2021 | Sep 23, 2021 |
| EFFECT | Filing | Aug 27, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 25, 2021 | — |
| CORRESP | Letter to the SEC | Aug 25, 2021 | — |
| S-3 | Shelf registration | Aug 16, 2021 | — |
| S-8 | Employee stock plan registration | Aug 16, 2021 | — |
| 10-Q | Quarterly report | Aug 16, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 16, 2021 | Aug 16, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 17, 2021 | Jun 16, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 16, 2021 | Jun 15, 2021 |
| 8-K |
Current report
Results of operations
|
May 14, 2021 | May 14, 2021 |
| 10-Q | Quarterly report | May 14, 2021 | Mar 31, 2021 |
| DEFA14A | Additional proxy material | Apr 28, 2021 | — |
| DEF 14A | Proxy statement | Apr 28, 2021 | Jun 16, 2021 |
| SEC STAFF LETTER | Filing | Apr 19, 2021 | — |
| SEC STAFF LETTER | Filing | Apr 19, 2021 | — |
| 8-K/A |
Amended current report
Officer or director change
|
Apr 16, 2021 | Mar 2, 2021 |
| EFFECT | Filing | Mar 24, 2021 | — |
| CORRESP | Letter to the SEC | Mar 22, 2021 | — |
| 8-K |
Current report
Material agreement, Other events
|
Mar 19, 2021 | Mar 18, 2021 |
| 424B5 | Prospectus supplement | Mar 19, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 18, 2021 | — |
| 424B5 | Prospectus supplement | Mar 18, 2021 | — |
| S-3 | Shelf registration | Mar 15, 2021 | — |
| 8-K |
Current report
Results of operations
|
Mar 15, 2021 | Mar 15, 2021 |
| 10-K | Annual report | Mar 15, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Officer or director change
|
Mar 5, 2021 | Mar 2, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 11, 2021 | Jan 11, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Dec 11, 2020 | Dec 10, 2020 |
| 8-K |
Current report
Officer or director change
|
Nov 20, 2020 | Nov 18, 2020 |
| 10-Q | Quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| D | Filing | Oct 26, 2020 | — |
| 8-K |
Current report
Other events
|
Oct 26, 2020 | Oct 23, 2020 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Other events
|
Oct 23, 2020 | Oct 22, 2020 |
| 8-K |
Current report
Other events
|
Oct 1, 2020 | Oct 1, 2020 |
| 10-Q | Quarterly report | Aug 6, 2020 | Jun 30, 2020 |
| S-8 | Employee stock plan registration | Aug 6, 2020 | — |
| 8-K |
Current report
Other events
|
Jul 27, 2020 | Jul 24, 2020 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 18, 2020 | Jun 16, 2020 |
| DEFA14A | Additional proxy material | May 22, 2020 | — |
| 8-K |
Current report
Other events
|
May 7, 2020 | May 7, 2020 |
| 10-Q | Quarterly report | May 7, 2020 | Mar 31, 2020 |
| DEFA14A | Additional proxy material | Apr 28, 2020 | — |
| DEF 14A | Proxy statement | Apr 28, 2020 | Jun 16, 2020 |
| 8-K |
Current report
Officer or director change, Other events
|
Apr 16, 2020 | Apr 15, 2020 |
| 10-K/A | Amended annual report | Mar 13, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Mar 12, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2020 | Mar 12, 2020 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Other events
|
Jan 9, 2020 | Jan 7, 2020 |
| 8-K |
Current report
Other events
|
Dec 18, 2019 | Dec 18, 2019 |
| 10-Q | Quarterly report | Nov 12, 2019 | Sep 30, 2019 |
| 424B3 | Prospectus | Oct 28, 2019 | — |
| EFFECT | Filing | Oct 25, 2019 | — |
| CORRESP | Letter to the SEC | Oct 23, 2019 | — |
| S-3/A | Filing | Oct 23, 2019 | — |
| CORRESP | Letter to the SEC | Oct 11, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 4, 2019 | — |
| S-3 | Shelf registration | Sep 3, 2019 | — |
| 10-Q | Quarterly report | Aug 14, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2019 | Aug 14, 2019 |
| D | Filing | Jul 31, 2019 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jul 26, 2019 | Jul 25, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2019 | Jun 13, 2019 |
| 10-Q | Quarterly report | May 13, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Results of operations
|
May 13, 2019 | May 13, 2019 |
| DEFA14A | Additional proxy material | May 3, 2019 | — |
| DEF 14A | Proxy statement | May 3, 2019 | Jun 13, 2019 |
| EFFECT | Filing | Mar 19, 2019 | — |
| CORRESP | Letter to the SEC | Mar 15, 2019 | — |
| UPLOAD | Letter from the SEC | Mar 14, 2019 | — |
| S-3 | Shelf registration | Mar 13, 2019 | — |
| 10-K | Annual report | Mar 13, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2019 | Mar 13, 2019 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- SLDB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Charlestown, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1707502
- Former names
- Solid Biosciences, LLC (until Jan 25, 2018)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.